Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype. [electronic resource]
Producer: 20110815Description: 381-91 p. digitalISSN:- 1876-7605
- Adenosine Diphosphate
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Aryl Hydrocarbon Hydroxylases -- genetics
- Aspirin -- administration & dosage
- Chi-Square Distribution
- Cilostazol
- Clopidogrel
- Cytochrome P-450 CYP2C19
- Drug Therapy, Combination
- Female
- Genotype
- Humans
- Korea
- Liver -- enzymology
- Male
- Middle Aged
- Myocardial Infarction -- blood
- Phenotype
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Function Tests
- Predictive Value of Tests
- Regression Analysis
- Risk Assessment
- Risk Factors
- Tetrazoles -- administration & dosage
- Thrombosis -- blood
- Ticlopidine -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.